genOway Stock Deutsche Boerse AG

Equities

JEH

FR0004053510

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG Other stock markets 02:05:59 2024-05-17 am EDT			5-day change	1st Jan Change
4.06 ^EUR	+0.50%		-1.22%	-7.94%

2023	GenOway: sharp rise, broker initiates buy recommendation	CF
2023	GENOWAY : Euroland initiates buy coverage	CF

on all our subscriptions*

Last Hours!

Take advantage of the offer

* See conditions on site

Financials

Sales 2021	19.59M 21.29M	Sales 2022	21.09M 22.92M	Capitalization	35.3M 38.36M
Net income 2021	- 0	Net income 2022	- 0	EV / Sales 2021	2.2 x
Net Debt 2021	5.22M 5.67M	Net Debt 2022	4.16M 4.52M	EV / Sales 2022	1.87 x
P/E ratio 2021 *	-	P/E ratio 2022	-	Employees	124
Yield 2021 *	-	Yield 2022	-	Free-Float	72.58%

More Fundamentals * Assessed data

Chart genOway

Duration

Period

Style

Dynamic Chart

Latest news about genOway

GenOway: sharp rise, broker initiates buy recommendation	Nov. 22	CF
GENOWAY : Euroland initiates buy coverage	Nov. 22	CF
GenOway: profitability target achieved ahead of schedule	23-09-22	CF
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Global markets live: Exxon Mobil, Apple, KKR, Amazon, Tesla...	23-04-11
GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI
Sigma-Aldrich and genOway Expand Their CRISPR/CAS9 Strategic Alliance	22-09-08	CI
GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
GenOway Grants the Leading UK Academic Research Funder A Non-Exclusive License for CRISPR/Cas9 Technology	22-01-25	CI
Global markets live: Michelin, Facebook, UBS, Tesla, Volvo...	21-10-26
Genoway Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-27	CI
GenOway Société anonyme announced that it has received €5.6 million in funding from NextStage AM	21-05-26	CI
GenOway Société anonyme announced that it expects to receive €5 million in funding from NextStage AM	21-05-05	CI
Genoway Soci?T? Anonyme Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Genoway S.A. Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-17	CI

More news

Analyst Recommendations on genOway

GenOway: sharp rise, broker initiates buy recommendation	Nov. 22	CF
GENOWAY : Euroland initiates buy coverage	Nov. 22	CF

More recommendations

Press releases genOway

GenOway : Résultats annuels 2023	Mar. 27	PU
GenOway : Résultats du 1er semestre 2023	23-09-22	PU
GenOway: Proposal of a new administrator	22-05-23	PU
GenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology	22-01-25	PR
GenOway : and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models	20-01-07	AQ

More press releases

News in other languages on genOway

Genoway : Organisation d’une visioconférence destinée aux investisseurs individuels	Mar. 28
Advicenne : Oncodesign, Plastic Omnium, Solvay...les valeurs à suivre aujourd'hui à Paris -	Mar. 27
En Direct des Marchés : Casino, Saint-Gobain, Vallourec, Johnson & Johnson, Roche, Hennes & Mauritz ...	Mar. 27
GenOway : A suivre aujourd'hui	Mar. 27
Advicenne : Genoway, SergeFerrari, Vantiva...les valeurs à suivre demain à Paris -	Mar. 26

More news

Quotes and Performance

1 day	+0.50%
1 week	-1.22%
Current month	+3.31%
1 month	+6.01%
3 months	+1.50%
6 months	+2.01%
Current year	-7.94%

More quotes

Highs and lows

1 week

3.99

4.06

1 month

3.78

4.35

Current year

3.65

4.67

1 year

3.46

4.68

3 years

2.75

4.70

5 years

1.07

6.00

10 years

1.07

6.00

More quotes

Managers and Directors - genOway

Managers	Title	Age	Since
Christian Grenier CEO	Chief Executive Officer	-	-
Alexandre Fraichard FOU	Founder	-	99-02-28
Benjamin Bruneau DFI	Director of Finance/CFO	-	15-09-30

Members of the board	Title	Age	Since
Alexandre Fraichard FOU	Founder	-	99-02-28
Raffy Kazandjian BRD	Director/Board Member	-	-
Patrick Blain BRD	Director/Board Member	72	-

More insiders

Quotes

Date	Price	Change
24-05-17	4.06	+0.50%
24-05-16	4.04	-0.25%
24-05-15	4.05	+0.75%
24-05-14	4.02	+0.75%
24-05-13	3.99	-2.92%

Delayed Quote Deutsche Boerse AG, May 17, 2024 at 02:05 am EDT

More quotes

Company Profile

Sector

Biotechnology & Medical Research

Calendar

2024-06-27 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+33.63%	50.93B
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B

Other Biotechnology & Medical Research

genOway Stock Deutsche Boerse AG

Equities

JEH

FR0004053510

Biotechnology & Medical Research

Financials EURUSD

Financials